Hi There,
I'm aiming to gather information from selected countries (All RoW) on the regulatory pathways for approval and market authorization of medicines that fall under FDA's classification of complex generics.
Anyone can help by providing weblinks to the relevant regulations on complex generics in any of the RoW countries except US and EU (EMA).
------------------------------
Thanks,
Amit K
India
------------------------------